October 10, 2024 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC)

Поділитися
Вставка
  • Опубліковано 17 жов 2024
  • The Committee will discuss new drug application (NDA) 215244, for elamipretide hydrochloride injection, submitted by Stealth BioTherapeutics Inc., for the treatment of Barth Syndrome.

КОМЕНТАРІ •